ArticlePublic health challenges2023
Enablers and barriers of COVID-19 vaccination efforts in Nepal.
Article in Public health challenges, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- COVID-19 vaccine acceptance and uptake in Indonesia, Nepal, and Vietnam: Key lessons from a qualitative study.PLOS global public health · 2026Article
- Impact of COVID-19 on Renal Transplant Recipients in a National Transplant Center.Immunity, inflammation and disease · 2025Article
- Enablers and barriers of COVID-19 vaccination efforts in Nepal.Public health challenges · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nepal, a landlocked country with a population of 29.1 million faced great socioeconomic, financial, and social hardships during the Coronavirus disease 2019 (COVID-19) pandemic. Nepal had increasing cases of COVID-19 despite multiple lockdowns and travel restrictions. Nepal reported 1,000,775 cases and 12,019 deaths till early November 2022. Timely government decisions, strategic political diplomacy, flexible vaccine policy, and multiple loan deals helped Nepal secure the COVID-19 vaccine from India in a commendable time frame. With the existing structure of the primary health care settings and experience of having implemented childhood vaccination campaigns, Nepal rolled out the COVID-19 vaccines across the nation on 27 January 2021. However, the delta wave was a devastating blow to South Asia with a high number of hospitalizations and deaths and a complete disruption of the COVID-19 vaccine supply from India. The government ran a relentless effort in COVID-19 vaccination and provided full vaccination to 33% of the total population by the end of 2021 and 81.1% by May 2022. The booster doses were administered beginning in 2022, but the campaign efforts have been lethargic with a coverage of only 29.2% and a lack of keen support from the public. The emergence of new variants of the virus continues to pose a challenge in controlling the disease and reopening the country to pre-pandemic levels of socioeconomic activities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.